Latest Biotechnology, Pharmaceutical and Healthcare News - Page: 3

13:27 EST 28th November 2015 | BioPortfolio

Showing News Articles 51–75 of 131

Wednesday 16th November 2011

Filtration Society meeting attracts delegates from seven countries

16 November 2011; Chester, UK:  Building on the success of previous years, a record number of delegates from seven different countries attended the latest Filtration Society two-day technical meeting. Held at the Ramada Hotel in Chester, UK in October, Filter Media 5 was the fifth international event focused on filter media and combined a training session, conference and exhibition. Pr...

Pantec Biosolutions Showcases P.L.E.A.S.E. Professional at MEDICA 2011 - Signs first research agreement with Copenhagens Bispebjerg University Hospital

Ruggell, Liechtenstein, 16th November 2011 - Pantec Biosolutions AG, a privately-owned company developing innovative dermal drug delivery products, will present its recently launched P.L.E.A.S.E.® Professional laser device at the MEDICA International Trade Fair from 16-19 November in Düsseldorf, Germany. Pantec Biosolutions’ P.L.E.A.S.E.® Professional is the world’s f...

Alcoholics' 'injured brains' work harder to complete simple tasks: Finger tapping study shows alcoholics may recruit other brain regions

Alcoholic brains can perform a simple finger-tapping exercise as well as their sober counterparts but their brain must work a lot harder to do it, according to a new study.

Tuesday 15th November 2011

BioVista Inc. Graham Anthony ,working with pharma companies to help them get best out of their own drugs

In this episode of PharmaTelevision News Review, Fintan Walton talks to Graham Anthouny, CFO of BioVista Inc.

European Biotechnology Network: Claire Skentelbery explains why partnerships are now the key thing to deliver technologies

In this episode of PharmaTelevision News Review, Paul Larsmon talks to Claire Skentelbery, Secretary General of European Biotechnology Network.

Mental illness: Early-life depression and anxiety changes structure of developing brain

New research identifies the brain chemicals and circuits involved in mental illnesses like schizophrenia, depression, and anxiety, giving potential new directions to their treatment. In addition, research with children shows that early-life depression and anxiety changes the structure of the developing brain.

Everybody can become a better a reader, Swedish research suggests

Students with cognitive impairments may learn to comprehend written texts much better than commonly thought, according to researchers in Sweden.

Watching less TV, being more active and sleeping more is linked to a healthy body weight in young children

Getting enough sleep can help children maintain a healthy weight, new research reveals. Similarly, the more time children spend in front of the TV or their computers (screen time), the higher their body weight.

Serotonin system in women's brains is damaged more readily by alcohol than that in men’s brains, study finds

After only four years of problem drinking, a significant decrease in the function of the serotonin system in women’s brains can be seen. This is the system that regulates such functions as impulse control and mood. It takes 12 years before a corresponding decrease is seen in men.

Gene impedes recovery from alcoholism, Swedish research finds

People who are alcohol-dependent and who also carry a particular variant of a gene run an increased risk of premature death, according to research from Sweden.

Healthcare of transsexual persons causes unnecessary suffering, Swedish study finds

In 1972, Sweden became the first country in the world to legislate healthcare for transsexualism within the state-financed healthcare system. In an international perspective, this was considered to be radical. It was expected that the life situation of people in the transsexual group would improve, now that state-financed healthcare was available for this group. New research from Sweden, however, ...

How the brain perceives shades of gray

Groundbreaking research provides new insight into how the brain perceives color.

Mimicking the brain -- in silicon: New computer chip models how neurons communicate with each other at synapses

For decades, scientists have dreamed of building computer systems that could replicate the human brain's talent for learning new tasks. Researchers have now taken a major step toward that goal by designing a computer chip that mimics how the brain's neurons adapt in response to new information. This phenomenon, known as plasticity, is believed to underlie many brain functions, including learning a...

Midatech receives Regulatory Approval for Clinically Testing Ultra-small Gold Nanoparticles

Oxford, UK, 15 November 2011 – Midatech Ltd., a global leader in the design, development, synthesis and manufacture of nanomedicines, announced today it has received Swissmedic approval to start the First-in-Human clinical trial with insulin-coated gold nanoparticles, which will be coordinated through its Swiss subsidiary PharMida AG. The trial is designed to assess the safety profile...

Positive Results from Phase 2 Trial of Mesoblast's Adult Stem Cell Therapy Presented at the American Heart Association Annual Meeting.

Revascor™, Mesoblast’s proprietary Mesenchymal Precursor Cell (MPC) product for cardiovascular diseases, was safe and well-tolerated at all doses, with no clinically relevant immune responses to donor cells Revascor™ therapy significantly reduced cardiac mortality and major adverse cardiac events (MACE) in patients with congestive heart failure over a mean follow-up o...

Mesoblast to Host Conference Call to Discuss RevascorTM Data Presented at American Heart Association

Melbourne, Australia; 15 November 2011: Global regenerative medicine company, Mesoblast Limited (ASX: MSB; OTC ADR: MBLTY), will host an investor conference call and webcast on Tuesday 15 November 8:15am Australian EDT (Monday, 14 November 2011 at 4:15pm U.S. EST, 9:15pm UK) following the presentation of data from its congestive heart failure clinical trial from 9:15am to 9:25am U.S. EST at t...

Monday 14th November 2011

PerkinElmer Targets Holistic Data Solutions

A series of acquisitions is expanding and refining the company’s focus, explains CSO Dan Marshak. November 15, 2011 | With its recent acquisitions of CambridgeSoft and Geospiza to name but two, PerkinElmer is signaling a new strategy that highlight...

NuMedii’s New Way to ‘De-Risk’ Drug Repositioning Work

Stanford University spin off relies on database to identify new drug uses. By Deborah Borfitz November 15, 2011 | A newly minted biotechnology company is offering to match the molecular genomic activity of previously approved medicines to that of kno...

Tooling up for Smarter Studies

Two industry studies found need for appropriate trial planning and tools. By Deborah Borfitz Novemer 15, 2011 | Separate industry surveys by information technology research and advisory firm Gartner and global software company ClearTrial make a stron...

An Inside Perspective on PAREXEL

One of the oldest clinical research organizations discusses technology and changes in the industry. November 15, 2011 | Mark Goldberg, PAREXEL’s chief operating officer, has been with the company since 1997 when he started the CRO’s medical imagi...

Got High Blood Pressure? Kiwi Fruit May Help

(3 stars)The story asks whether kiwi is the How is this newsworthy?

A Portable Glow to Help Melt Those Winter Blues

(3 stars)After almost two decades of research on light therapy, this story hints at but does not explore the real news: why isn't it more commonly prescribed?

High childhood IQ linked to subsequent illicit drug use, research suggests

A high childhood IQ may be linked to subsequent illegal drug use, particularly among women, new research suggests.

Telephone-based therapy and exercise appear effective for reducing chronic widespread pain

Telephone-delivered cognitive behavioral therapy and an exercise program, both separately and combined, are associated with short-term positive outcomes for patients with chronic widespread pain, and may offer benefits for patients diagnosed with fibromyalgia, according to a new report.

GE Healthcare expands Biacore™ histidine capture portfolio with launch of His Capture Kit and NTA Reagent Kit

November 14 2011: GE Healthcare has launched the His Capture Kit and NTA Reagent Kit for time saving and convenient capture of histidine-tagged ligands using Biacore systems. The new His Capture Kit comprises of an optimized protocol and the required reagents for capture by an anti-histidine antibody. Requiring minimum assay development, the kit works in conjunction with a carboxyl-derivatize...


BioPortfolio's biotechnology, pharmaceutical, healthcare and medical device information service collates press releases, news articles and blogs from over 275 sources.